- Published on:
Tehran, Feb 17 (Prensa Latina) An Iranian pharmaceutical company has concluded the clinical trials in animals of a vaccine against the Omicron SARS-CoV-2 variant with 100 percent effectiveness, a health communique reported on Thursday.